Great Point Partners

Great Point Partners operates as a specialized healthcare investment firm, deploying capital across both private and public markets. The firm manages lower middle market growth buyout funds dedicated to private healthcare companies, alongside a hedge fund, the BioMedical Value Fund (BMVF), which targets small and mid-capitalization publicly traded biotechnology and life sciences enterprises. Their approach combines deep sector expertise with a fundamentally focused investment strategy, aimed at uncovering asymmetric risk-reward opportunities within the complex healthcare landscape.

The firm was founded in 2003 by Jeffrey R. Jay, M.D., with a clear vision to support burgeoning healthcare companies in realizing their full potential while simultaneously advancing global healthcare solutions. Dr. Jay brought extensive private equity experience to the endeavor, establishing a firm centered on a collaborative, partnership-driven model. This foundation was built on the insight that strategic investment and operational guidance could significantly impact the growth trajectory of healthcare innovators.

Great Point Partners primarily serves the management teams of growing, profitable healthcare companies seeking strategic and financial partners, as well as publicly traded life sciences companies focused on drug development. The firm’s overarching mission is to actively contribute to the evolution of healthcare by fostering solutions that are better, faster, and more cost-effective. It aims to empower its portfolio companies and public market investments to drive transformative progress in patient care and medical innovation.